Early stage epithelial ovarian cancers: A study of morphologic prognostic factors

Pathology Research and Practice

Volumn 209, Issue 6, 2013, Pages 359-364

  Terzi, Aysen ^a   Aktaş, Isil Yildiz ^b   Dolgun, Anil ^c   Ayhan, Ali ^a   Küçükali, Türkan ^c   Usubütün, Alp ^c  

^a BASKENT UNIVERSITY   (Turkey)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Early ovarian carcinoma; FIGO stage; Mitosis; Prognosis; Universal grade

Indexed keywords

ADULT; ARTICLE; BILATERAL CANCER; CANCER CLASSIFICATION; CANCER GRADING; CANCER MORPHOLOGY; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CYSTADENOMA; DISEASE FREE SURVIVAL; ENDOMETRIOSIS; FEMALE; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS POTENTIAL; MITOSIS INDEX; OVARY CARCINOMA; OVERALL SURVIVAL; RECURRENCE RISK; RELIABILITY;

ADULT; CARCINOMA; CHI-SQUARE DISTRIBUTION; CYSTADENOMA; DISEASE-FREE SURVIVAL; ENDOMETRIOSIS; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; MITOTIC INDEX; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; TUMOR BURDEN; TURKEY;

EID: 84878404459     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2013.03.009     Document Type: Article

References (23)

1. Tumours of the Ovary and Peritoneum, in: World Health Organization Classification of Tumours. Pathology and Genetics. Tumours of the Breast and Female Genital Organs 2003, 113-202. IARC Press, Lyon. F.A. Tavassoli, P. Devilee (Eds.).
2. Paulsen T., Kærn J., Tropé C. Improved 5-year disease-free survival for FIGO stage I epithelial ovarian cancer patients without tumor rupture during surgery. Gynecol. Oncol. 2011, 122(1):83-88.
3. Chan J.K., Tian C., Monk B.J., et al. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study. Cancer 2008, 112:2202-2210.
4. Bertelsen K., Hølund B., Andersen J.E., Nielsen K., Strøyer I., Ladehoff P. Prognostic factors and adjuvant treatment in early epithelial ovarian cancer. Int. J. Gynecol. Cancer 1993, 3(4):211-218.
5. Vergote I. Prognostic factors in stage I ovarian carcinoma. Verh. K Acad. Geneeskd. Belg. 2001, 63(3):257-271.
6. Sevelda P., Vavra N., Schemper M., Salzer H. Prognostic factors for survival in stage I epithelial ovarian carcinoma. Cancer 1990, 65:2349-2352. May.
7. Nguyen H.N., Averette H.E., Hoskins W., Sevin B.U., Penalver M., Steren A. National survey of ovarian carcinoma. VI. Critical assessment of current International Federation of Gynecology and Obstetrics staging system. Cancer 1993, 72:3007-3011.
8. Tropé C., Kaern J., Hogberg T., et al. Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument. Ann. Oncol. 2000, 11(3):281-288.
9. International Federation of Gynecology Obstetrics Classification and staging of malignant tumours in the female pelvis. Acta Obstet. Gynecol. Scand. 1971, 50:1-7.
10. Shimizu Y., Kamoi S., Amada S., Akiyama F., Silverberg S.G. Toward the development of a universal grading system for ovarian epithelial carcinoma: testing of a proposed system in a series of 461 patients with uniform treatment and follow-up. Cancer 1998, 82:893-901.
11. Silverberg S.G. Histopathologic grading of ovarian carcinomas: a review and proposal. Int. J. Gynecol. Pathol. 2000, 19:7-15.
12. Ishioka S., Sagae S., Terasawa K., et al. Comparison of the usefulness between a new universal grading system for epithelial ovarian cancer and the FIGO grading system. Gynecol. Oncol. 2003, 89(3):447-452.
13. Mayr D., Diebold J. Grading of ovarian carcinomas. Int. J. Gynecol. Pathol. 2000, 19(4):348-353.
14. Petru E., Lück H.J., Stuart G., Gaffney D., Millan D., Vergote I. Gynecologic Cancer Intergroup (GCIG) proposals for changes of the current FIGO staging system. Eur. J. Obstet. Gynecol. Reprod. Biol. 2009, 143(2):69-74.
15. Haapasalo H., Collan Y., Seppä A., Gidlund A.L., Atkin N.B., Pesonen E. Prognostic value of ovarian carcinoma grading methods-a method comparison study. Histopathology 1990, 16:1-7.
16. Malpica A., Deavers M.T., Lu K., et al. Grading ovarian serous carcinoma using a two-tier system. Am. J. Surg. Pathol. 2004, 28(4):496-504.
17. Aune G., Stunes A.K., Tingulstad S., Salvesen O., Syversen U., Torp S.H. The proliferation markers Ki-67/MIB-1, phosphohistone H3, and survivin may contribute in the identification of aggressive ovarian carcinomas. Int. J. Clin. Exp. Pathol. 2011, 4(5):444-453.
18. Mizuno M., Kikkawa F., Shibata K., et al. Long-term follow-up and prognostic factor analysis in clear cell adenocarcinoma of the ovary. J. Surg. Oncol. 2006, 94(2):138-143.
19. Chan J.K., Teoh D., Hu J.M., Shin J.Y., Osann K., Kapp D.S. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers. Gynecol. Oncol. 2008, 109(3):370-376.
20. Ayhan A., Gultekin M., Taskiran C., et al. Lymphatic metastasis in epithelial ovarian carcinoma with respect to clinicopathological variables. Gynecol. Oncol. 2005, 97(2):400-404.
21. Powless C.A., Aletti G.D., Bakkum-Gamez J.N., Cliby W.A. Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical staging. Gynecol. Oncol. 2011, 122(3):536-540.
22. Kurman R.J., Shih Ie.M. Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications. Int. J. Gynecol. Pathol. 2008, 27(2):151-160.
23. Prowse A.H., Manek S., Varma R., et al. Molecular genetic evidence that endometriosis is a precursor of ovarian cancer. Int. J. Cancer 2006, 119:556-562.